Goldman Sachs’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $3.26M | Buy |
|
|||||
|
2018
Q2 | $2.25M | Sell |
|
|||||
|
2018
Q1 | $3.32M | Buy |
|
|||||
|
2017
Q4 | $744K | Buy |
|
|||||
|
2017
Q3 | $16K | Sell |
|
|||||
|
2017
Q2 | $646K | Buy |
|
|||||
|
2017
Q1 | $95K | Sell |
|
|||||
|
2016
Q4 | $213K | Buy |
|
|||||
|
2016
Q3 | $160K | Sell |
|
|||||
|
2016
Q2 | $243K | Sell |
|
|||||
|
2016
Q1 | $400K | Buy |
|
|||||
|
2015
Q4 | $67K | Buy |
|
|||||
|
2015
Q3 | $61K | Sell |
|
|||||
|
2015
Q2 | $138K | Buy |
|
|||||
|
2015
Q1 | $158K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $90K | Sell |
|
|||||
|
2014
Q2 | $665K | Buy |
|
|||||
|
2014
Q1 | $305K | Sell |
|
|||||
|
2013
Q4 | $294K | Buy |
|
|||||
|
2013
Q3 | $323K | Buy |
|
|||||
|
2013
Q2 | $180K | Buy |
|